<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26403305</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>07</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1179-1950</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>75</Volume>
            <Issue>15</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drugs</Title>
          <ISOAbbreviation>Drugs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Saxagliptin: A Review in Type 2 Diabetes.</ArticleTitle>
        <Pagination>
          <StartPage>1783</StartPage>
          <EndPage>1796</EndPage>
          <MedlinePgn>1783-96</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40265-015-0473-z</ELocationID>
        <Abstract>
          <AbstractText>Saxagliptin (Onglyza(®)) is a highly potent, reversible, competitive dipeptidyl peptidase-4 inhibitor indicated for the treatment of patients with type 2 diabetes. Numerous well-designed clinical studies and their extensions showed that saxagliptin as monotherapy or as dual or triple combination therapy with other antihyperglycaemics improved glycaemic control and was generally well tolerated in patients with type 2 diabetes during ≤2 years' therapy. Saxagliptin was generally weight-neutral and had a low risk of hypoglycaemia (unless coadministered with agents that may be associated with hypoglycaemia, such as sulfonylureas or insulin). In addition, at a median follow-up of 2.1 years in the large SAVOR-TIMI 53 study, with the exception of a 27 % greater risk of hospitalization for heart failure, the addition of saxagliptin to standard of care neither reduced nor increased the rate of ischemic cardiovascular events in at-risk patients. Although further long-term data will be beneficial, current evidence indicates that saxagliptin is a useful option for the treatment of patients with type 2 diabetes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dhillon</LastName>
            <ForeName>Sohita</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand. demail@springer.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>New Zealand</Country>
        <MedlineTA>Drugs</MedlineTA>
        <NlmUniqueID>7600076</NlmUniqueID>
        <ISSNLinking>0012-6667</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9GB927LAJW</RegistryNumber>
          <NameOfSubstance UI="C502994">saxagliptin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>PJY633525U</RegistryNumber>
          <NameOfSubstance UI="D000218">Adamantane</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000218" MajorTopicYN="N">Adamantane</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>9</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>9</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26403305</ArticleId>
        <ArticleId IdType="doi">10.1007/s40265-015-0473-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s40265-015-0473-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Curr Med Res Opin. 2012 Oct;28(10):1635-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23020253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Jan;38(1):140-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25538310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2013 Oct 3;369(14):1317-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23992601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Heart J. 2011 Nov;162(5):818-825.e6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22093196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Metab Res Rev. 2014 Oct;30(7):556-69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24376173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pharmacol. 2012 Apr 04;12:2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22475049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2009 Sep;32(9):1649-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19478198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Jan;38 Suppl:S33-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25537705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Heart Fail. 2014 Jun;16(6):603-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24687300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Clin Pract. 2011 Dec;65(12):1230-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21977965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Manag Care Pharm. 2014 Feb;20(2):120-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24456313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardiovasc Diabetol. 2014 Feb 04;13:33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24490835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Med Res Opin. 2012 Apr;28(4):513-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22313154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2013 Oct;34(39):3035-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23996285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2015 May;17(5):487-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25656169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Metab Res Rev. 2013 Jul;29(5):417-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23564755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Med Res Opin. 2011 Nov;27 Suppl 3:57-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22106978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2012 Apr;14(4):365-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22192246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Metab Res Rev. 2012 Mar;28(3):268-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22081481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2014 Sep;37(9):2435-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24914244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Clin Pract. 2010 Nov;64(12):1619-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20846286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Endocrinol Metab. 2009 Dec;94(12):4810-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19864452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2009 Jan 8;360(2):129-39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19092145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2008 Jun 12;358(24):2545-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18539917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Apr;38(4):696-705</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25552421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2011 Jun;13(6):523-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21332627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Jan;38 Suppl:S41-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25537707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Clin Pract. 2009 Sep;63(9):1395-406</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19614786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2013 Oct 3;369(14):1327-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23992602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Jun;38(6):1145-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25758769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Exp Clin Endocrinol Diabetes. 2014 Sep;122(8):469-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24838155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2015 Jul 16;373(3):232-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26052984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2011 Jun;13(6):567-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21342412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diab Vasc Dis Res. 2011 Apr;8(2):150-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21562067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2008 Jun 12;358(24):2560-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18539916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Pract. 2015 Apr;21(4):438-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25877012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2015 Jun 4;372(23):2197-206</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26039600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabet Med. 2013 Dec;30(12):1472-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23802840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diab Vasc Dis Res. 2011 Apr;8(2):125-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21562064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetol Metab Syndr. 2014 May 31;6:69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24917890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2009 Jun;11(6):611-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19515181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardiovasc Hematol Agents Med Chem. 2012 Dec;10(4):276-88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22827291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2008 Oct 9;359(15):1577-89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18784090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diab Vasc Dis Res. 2015 May;12(3):154-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25852133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2014 May;16(5):443-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24205943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Circulation. 2014 Oct 28;130(18):1579-88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25189213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Med Res Opin. 2009 Oct;25(10):2401-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19650754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Drug Investig. 2013 Oct;33(10):707-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23949898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2015 May 23;385(9982):2067-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25765696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Obes Metab. 2015 Jul;17(7):630-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25761977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2015 Nov;38(11):2142-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26358285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med. 2010 May;122(3):16-27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20463410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Care. 2009 Jan;32(1):187-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19092168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Interv Aging. 2014 Sep 04;9:1479-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25214775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes. 2014 Jul;63(7):2196-202</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24962916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Metab Res Rev. 2010 Oct;26(7):540-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20824678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 2012 Jan 22;72(2):229-48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22221000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetes Ther. 2013 Dec;4(2):431-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24163113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Clin Pract. 2013 Apr;67(4):307-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23638466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endocr Pract. 2015 Apr;21 Suppl 1:1-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25869408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabetol Metab Syndr. 2012 Jul 24;4(1):36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22828124</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
